VJDementia is committed to improving our service to you

EAN 2020 | Alzheimer’s disease: what are the challenges when disease-modifying therapies become available?

VJDementia is committed to improving our service to you

Paola Barbarino

Paola Barbarino, CEO, Alzheimer’s Disease International, outlines the challenges to prepare healthcare systems for the diagnosis, treatment, and care of Alzheimer’s disease in a future with disease-modifying therapies. This interview was recorded during an online conference call with The Video Journal of Dementia (VJDementia).

Share this video